Skip to main content

The Man Who Made Millions by Marketing Monoclonal Antibodies

SAN DIEGO—When Ivor Royston founded his first biotech company in 1978, the 33-year-old assistant professor at the University of California, San Diego had no idea it would make him so rich and...infamous. Royston did know he was taking a risk. But his idea, to start the first company in the nation to sell monoclonal antibodies to other labs, was so compelling that he decided to gamble his career at UCSD. “I had only been there a year. I wasn’t even tenured,” recalls

Written byAnn Gibbons
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00

SAN DIEGO—When Ivor Royston founded his first biotech company in 1978, the 33-year-old assistant professor at the University of California, San Diego had no idea it would make him so rich and...infamous.

Royston did know he was taking a risk. But his idea, to start the first company in the nation to sell monoclonal antibodies to other labs, was so compelling that he decided to gamble his career at UCSD. “I had only been there a year. I wasn’t even tenured,” recalls Royston, going on to say: "I thought it might jeopardize my career, but I also had a gut feeling that this was the right thing to do,”

Financially, the grand gamble paid off. Today, at 43, Royston is immensely wealthy, the founder of two biotechnology companies and still a university professor. He works in his lab, conducts clinical trials at the UCSD medical center, and spends a couple ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo